Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Affective disorders and cognitive performance. A clinical report.

R J Kerry, C M McDermott, J E Orme

    Journal of Affective Disorders
    |November 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Differences in statin associated neuroprotection corresponds with either decreased production of IL-1β or TNF-α in an in vitro model of neuroinflammation-induced neurodegeneration.

    Toxicology and applied pharmacology·2018
    Same author

    Site of action of GABA(B) receptor for vagal motor control of the lower esophageal sphincter in ferrets and rats.

    Gastroenterology·2001
    Same author

    The cyanobacterial toxin, microcystin-LR, can induce apoptosis in a variety of cell types.

    Toxicon : official journal of the International Society on Toxinology·1998
    Same author

    Detection of cyanobacterial toxins (microcystins) in waters of northeastern Wisconsin by a new immunoassay technique.

    Toxicon : official journal of the International Society on Toxinology·1995
    Same author

    Deacylation of endotoxin during natural cases of bovine mastitis.

    Journal of dairy science·1991
    Same author

    Intracellular and extracellular enzymatic deacylation of bacterial endotoxin during localized inflammation induced by Escherichia coli.

    Infection and immunity·1991

    Bipolar disorder patients can fully recover without cognitive decline, even after decades of illness and numerous episodes. Traditional treatments like medication and electroconvulsive therapy (ECT) do not necessarily cause lasting cognitive impairment.

    Area of Science:

    • Psychiatry
    • Neurology
    • Clinical Psychology

    Background:

    • Bipolar disorder (manic-depressive illness) is a chronic mental health condition.
    • Concerns exist regarding potential cognitive deterioration from long-term illness and treatments.
    • Previous research has not definitively established recovery potential without cognitive decline.

    Purpose of the Study:

    • To investigate the long-term recovery outcomes in patients with bipolar disorder.
    • To assess whether complete recovery is possible without cognitive deterioration.
    • To evaluate the impact of traditional psychiatric treatments on cognitive function.

    Main Methods:

    • A cohort of 27 patients diagnosed with bipolar disorder was studied.
    • Patient histories included up to 65 years of illness duration and 100 manic/depressive episodes.

    Related Experiment Videos

  • Review of treatment histories, including traditional pharmacological and physical therapies (e.g., electroconvulsive therapy - ECT).

    • Main Results:

    • All 27 patients achieved complete recovery from bipolar disorder.
    • No instances of cognitive deterioration were observed in the study group.
    • Patients who underwent traditional treatments (medication, ECT) showed no resultant cognitive impairment.

    Conclusions:

    • Bipolar disorder is a treatable condition with potential for full recovery.
    • Complete remission is achievable without irreversible cognitive deficits.
    • Standard psychiatric interventions do not inherently lead to cognitive deterioration in bipolar disorder patients.